2023 - Research.com Best Female Scientist Award
2022 - Research.com Best Female Scientist Award
2010 - Fellow of the American Association for the Advancement of Science (AAAS)
Susan Buchbinder mainly investigates Immunology, Acquired immunodeficiency syndrome, Virology, Men who have sex with men and Allele. The various areas that Susan Buchbinder examines in her Acquired immunodeficiency syndrome study include Internal medicine, Cohort study and Risk factor. Her work deals with themes such as HIV vaccine and Placebo, which intersect with Internal medicine.
Her Virology research is multidisciplinary, incorporating elements of Heterozygote advantage, Antibody and Gene. Particularly relevant to Pre-exposure prophylaxis is her body of work in Men who have sex with men. She interconnects Mutation, Disease, Pathogenesis and Genotype in the investigation of issues within Allele.
Susan Buchbinder spends much of her time researching Immunology, Men who have sex with men, Acquired immunodeficiency syndrome, Virology and Internal medicine. Susan Buchbinder has researched Immunology in several fields, including HIV vaccine and Allele. Susan Buchbinder mostly deals with Pre-exposure prophylaxis in her studies of Men who have sex with men.
Her study in Pre-exposure prophylaxis is interdisciplinary in nature, drawing from both Intensive care medicine and Emtricitabine. Her research in Acquired immunodeficiency syndrome intersects with topics in Seroconversion, Cohort study, Cohort and Risk factor. Susan Buchbinder has researched Virology in several fields, including Epitope, Cytotoxic T cell, CTL* and Genotype.
The scientist’s investigation covers issues in Pre-exposure prophylaxis, Family medicine, Men who have sex with men, Public health and Immunology. Her Pre-exposure prophylaxis research incorporates elements of Homosexuality, Intensive care medicine, Internal medicine, Dapivirine and Emtricitabine. Her work deals with themes such as Clinical trial, Tenofovir, Hiv testing, Acquired immunodeficiency syndrome and Transgender women, which intersect with Family medicine.
Her work is dedicated to discovering how Men who have sex with men, Randomized controlled trial are connected with Test and Health intervention and other disciplines. Her Public health research is multidisciplinary, incorporating perspectives in Mental health, Epidemiology, Pregnancy and Antiretroviral therapy. As part of her studies on Immunology, she frequently links adjacent subjects like Receptor.
Her primary areas of study are Pre-exposure prophylaxis, Family medicine, Primary care, Intensive care medicine and Confidence interval. Her work carried out in the field of Pre-exposure prophylaxis brings together such families of science as Internal medicine, Emtricitabine, Antiretroviral therapy and Collective impact. The Internal medicine study combines topics in areas such as Gastroenterology, Immunoassay and Seroconversion.
Her Family medicine research includes elements of HIV vaccine and AIDS Vaccines. Her Health intervention research is multidisciplinary, incorporating elements of Odds ratio, Men who have sex with men, Clinical trial, Randomized controlled trial and Generalized estimating equation. Her Men who have sex with men study combines topics from a wide range of disciplines, such as Test and Framingham Risk Score.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
Robert M. Grant;Javier R. Lama;Peter L. Anderson;Vanessa McMahan.
The New England Journal of Medicine (2010)
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene
Michael Dean;Mary Carrington;Cheryl Winkler;Gavin A. Huttley.
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
Susan P Buchbinder;Devan V Mehrotra;Ann Duerr;Daniel W Fitzgerald.
The Lancet (2008)
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
Mary Carrington;George W. Nelson;Maureen P. Martin;Teri Kissner.
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Maureen P. Martin;Xiaojiang Gao;Jeong Hee Lee;George W. Nelson.
Nature Genetics (2002)
Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression
Michael W. Smith;Michael Dean;Mary Carrington;Cheryl Winkler.
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
Robert M. Grant;Robert M. Grant;Robert M. Grant;Peter L. Anderson;Vanessa McMahan;Albert Liu.
Lancet Infectious Diseases (2014)
Genetic Restriction of AIDS Pathogenesis by an SDF-1 Chemokine Gene Variant
Cheryl Winkler;William Modi;Michael W. Smith;George W. Nelson.
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.
Giuseppe Pantaleo;Stefano Menzo;Mauro Vaccarezza;Cecilia Graziosi.
The New England Journal of Medicine (1995)
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.
Peter L. Anderson;David V. Glidden;Albert Liu;Susan Buchbinder.
Science Translational Medicine (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: